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Abstract
The current study examined the effect of acute caffeine ingestion on mean and peak power
production, fatigue index and rating of perceived exertion (RPE) during upper body and lower
body Wingate anaerobic test (WANT) performance. Using a double-blind design, 22 males
undertook one upper body and one lower body WANT, 60 min following ingestion of caffeine
(5 mg*kg-1) and one upper body and one lower body WANT following ingestion of placebo (5
mg*kg-1 Dextrose). Peak power was significantly higher (P=.001) following caffeine ingestion
in both upper and lower body WANT. Peak power and mean power was also significantly 
higher during lower body, compared to upper body WANTs irrespective of substance ingested.
However, caffeine ingestion did not enhance mean power neither in upper nor lower-body 
WANT. There were no significant differences in mean fatigue index as a consequence of
substance ingested or mode of exercise (all P>0.05). For RPE there was also a significant 
substance ingested X mode interaction (P = .001) where there were no differences in RPE
between caffeine and placebo conditions in lower body WANTs but significantly lower RPE
during upper body WANT in the presence of caffeine compared to placebo (P = .014). This is
the first study to compare the effects of caffeine ingestion on upper and lower body 30-second 
WANT performance and suggests that caffeine ingestion in the dose of 5 mg*kg-1 ingested 60 
min prior to exercise significantly enhances peak power when data from upper and lower body 
WANTs are combined.
Keywords: Wingate test; high-intensity exercise; cognition; ergogenic aid; nutrition.
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Introduction
Caffeine is a widely used supplement as a means to enhance exercise performance and the
beneficial effects of ingesting this substance are well reported (Graham, 2001; Astorino & 
Roberson, 2010). The majority of this prior work supports the beneficial effects of caffeine 
ingestion on tasks that are predominantly aerobic in nature whereas, there is greater 
equivocality with respect to tests requiring anaerobic components of performance (Davis & 
Green, 2009). This has resulted in an increasing interest in caffeine responses to tests 
requiring maximal strength and power (Grgic & Mikulic, 2017), resistance exercise to failure 
(Astorino & Roberson, 2010) and the Wingate anaerobic test (WANT; Duncan, Dobell, Caygill, 
Eyre, & Tallis, 2018; Greer, McLean, & Graham, 1998; Salinero et al., 2017). The WANT test
is widely used due to its simplicity, validity to estimate anaerobic performance, and high
reliability (Bar-Or, 1987). In the context of WANT performance, studies have reported ergolytic 
effects (Greer et al., 1998), whilst others have reported significantly increased peak and mean 
power output following caffeine ingestion (Salinero et al., 2017).
Grgic (2018), recognising the equivocality on this topic, recently presented meta-
analytical data examining the effects of caffeine ingestion on anaerobic exercise. This meta-
analysis of 16 studies concluded that acute caffeine ingestion augments lower body peak and
mean power produced during the WANT. One limitation of the studies included in the meta-
analysis by Grgic (2018) is that none of them examined the effectiveness of the blinding to the
caffeine and placebo conditions. This limitation may be relevant given that correct supplement
identification may impact the exercise outcome and therefore present a source of bias in
studies investigating the effects of caffeine ingestion on exercise performance (Saunders et 
al., 2017). The inclusion of studies that did not examine the efficacy of the blinding to caffeine
and placebo trials in the analysis might have confounded the pooled meta-analytical results 
by Grgic (2018). This limitation highlights the need for future studies exploring the effects of
caffeine on WANT performance whilst addressing this methodological limitation. 
 
 
         
     
    
     
    
       
      
  
   
 
   
    
        
   
    
    
     
      
   
        
      
         
   
 
 
       
  
4
Grgic (2018) also noted that none of the included studies examined the effect of
caffeine ingestion on upper body WANT performance and no studies compared upper versus 
lower body WANT performance in the presence of caffeine (Grgic, 2018). Despite previous 
work demonstrating caffeine induced increases in upper body strength (Bazzucchi, Felici,
Montini, Figura, & Sacchetti, 2011), there is evidence to suggest that the effects of caffeine 
may not be uniform across the upper and lower body (Grgic & Mikulic, 2017; Tallis & Yavuz,
2018). It has been suggested that in smaller muscles, such as those of the upper arm, there
may be a limited ability for increased motor unit recruitment associated with caffeine ingestion 
(Warren, Park, Maresca, McKibans, & Millard-Stafford, 2010). Therefore, the evidence on the
acute performance-enhancing effects of caffeine in the lower body WANT cannot necessarily
be generalised to the upper body musculature. Whilst meta-analyses suggest that caffeine 
ingestion may have a greater ergogenic effect on the lower body than upper body musculature, 
these results are generally obtained by pooling studies that examined the effects of caffeine
on either upper or lower body exercise performance (Grgic & Pickering, 2018; Warren et al., 
2010). In other words, currently, there is a lack of studies using tests for both upper and lower 
body in the same group of participants which is an avenue requiring further scientific attention.
Recently, Duncan et al. (2018) examined the effects of acute caffeine ingestion on
power output during the upper body WANT following the ingestion of 5mg*kg-1 of caffeine in a 
sample of 12 males. They reported that caffeine ingestion, as compared to placebo, resulted
in: (1) increased peak power (but not mean power); (2) higher fatigue rate; and (3) lower rating 
of perceived exertion (RPE). While these results support similar studies that have been
conducted using lower body WANT, there are few studies that have examined whether
caffeine ingestion has a differential effect on upper or lower body WANT exercise 
performance. 
Understanding if caffeine influences perceptual responses to upper body exercise
compared to lower body exercise is important in exercise prescription and planning training 
programmes. Perception of exertion may be amplified during upper body exercise (Kang, 
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Chaloupka, Mastrangelo, & Angelucci, 1999) as less extraneous sensory information is 
processed when using a smaller muscle mass (Pandolf, Billings, Drolet, Pimental, & Sawka,
1984) and cerebral blood flow is greater for upper body, compared to lower body exercise
(Thomas, Schroeder, Secher, & Mitchell, 1989).
The current study sought to address a key gap in the literature by comparing the effect 
of acute caffeine ingestion on mean and peak power production and RPE during upper body 
and lower body WANT performance. We hypothesised that caffeine ingestion would enhance
both mean and peak power both in the lower and upper body WANT.
Methods
Participants
Following institutional ethics approval and informed consent, 23 males agreed to 
participate. Of that sample, one participant withdrew midway through the testing period due to
illness, resulting in a sample of 22 males (aged 18-30; 22.4±3.7 years; height 174±0.7cm;
body mass 76.0±12.2kg; mean±SD) who completed the testing sessions. All participants 
habitually ingested caffeine although none were heavy caffeine users (mean ± SD of caffeine
consumption = 141.6 ± 35.8 mg/day, range = 90-240 mg/day). Caffeine intake was established
using a 24-hour recall questionnaire (Maughan, 1999). All participants completed a health 
history questionnaire to ensure that they were “apparently healthy” and accustomed to regular
high-intensity exercise. Participants were excluded if they had a musculoskeletal injury or
cardiovascular condition that restricted exercise performance or were a heavy habitual 
caffeine user (>300mg/day). One volunteer was excluded on expressing interest in taking part
in the project based on heavy caffeine habitual consumption and was not included in the initial
sample taking part in the study. Male participants were specifically recruited as, in women, the
use of oral contraceptives and menstrual cycle phases can alter caffeine metabolisation
speeds (Rietveld, Broekman, Houben, Eskes, & Van Rossum, 1984). In turn, these factors
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may affect the ergogenic effects of caffeine. Therefore, to eliminate any confounding effects
due to the inclusion of both sexes, we opted to explore the effects of caffeine on WANT
performance while only including men. 
Procedures
All testing took place between 9.00 am and 12.00 noon with each condition taking 
place at the same time of day for each participant. The half-life of caffeine is generally 4 to 6 
hours (Graham, 2001); therefore this time of caffeine abstinence should be sufficient to
eliminate any confounding effects of prior caffeine consumption. Participants were asked to
refrain from vigorous exercise, maintain normal dietary patterns in the 48 h prior to testing and
were asked not to consume caffeine after 6:00 pm the night before testing (Marlat & 
Rosenhow, 1980). Each participant undertook five visits to the human performance laboratory. 
In the first visit they were familiarised with the equipment and procedures involved in the study.
All of the participants had prior experience of undertaking both upper and lower body WANTs
within the preceding 3 months to engaging in the current study and were familiar with the 
protocols being employed. However, this first visit also comprised a habituation to the WANTs 
and verification of maximal cadence to be used in the subsequent experimental trials. In the
following four experimental trials participants undertook either an upper body WANT, 60
minutes following ingestion of either caffeine or placebo or a lower body WANT following
ingestion of either caffeine or placebo. Order of exercise trial was randomised using GraphPad
randomisation software (GraphPad, San Diego, USA) freely available at: 
https://www.graphpad.com/quickcalcs/randomize1.cfm.
Prior to the experimental trials, participants ingested either 5 mg*kg-1 body mass of 
caffeine (Myprotein, UK) or a placebo (5 mg*kg-1 dextrose, Myprotein, UK) administered in
gelatine capsules with 200 ml water. Substances were presented double blind and in a 
counterbalanced order. Substances were consumed 60 minutes before each exercise trial as 
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plasma caffeine concentration is maximal approximately 1 hour after ingestion of caffeine 
(Graham, 2000). 
Exercise Protocol and Performance Measures
The exercise tests consisted of 30 second upper or lower body WANTs completed on
a Monark Peak bike (Ergomedic 894E, Vansbro, Sweden) and executed following
recommended guidelines (Peterson, 2012). The ergometer was calibrated prior to any testing
being conducted. A fly wheel braking force corresponding to 0.05kg/per kg body mass (Nindl, 
Mahar, Harman, & Patton, 1995) was used for upper body WANT and 0.075kg/per kg body 
mass for lower body WANTs. Prior to each test commencing, participants completed a
standardised, 4-minute warm up at a load against a load of 1 kg, followed by 3 × 2 s maximal 
cycling against a load of 7.5% (lower body) or 5% (upper body) body mass, interspersed with 
45 s easy cycling following the procedure reported by Kavaliauskas and Phillips (2016). After 
a short gap (standardised to 1 minute), the participant was then asked to begin cranking or
cycling at maximal cadence against no load. Once the participant was at maximal cadence
the external load was applied for 30 seconds. Care was made to ensure participants remained
seated throughout. The peak power output mean power output, and fatigue index (%) were
calculated during the WANT using custom software sampling data at 0.5 second intervals. 
Peak power was defined as the highest power output achieved during any 0.5 second interval
and mean power was defined as the average power over the 30 second test. Using a WANT
protocol the same as that reported here, Kavaliauskas and Phillips (2016) reported that the 
test-retest reliability of peak and mean power in the WANT is very high (intraclass correlation
coefficient: 0.93 and 0.99, respectively).
During each WANT, peak heart rate (PHR) was assessed using heart rate telemetry, 
sampling at 5Hz (RS400 Polar Electro Oy, Kempele, Finland) and on completion of each test
RPE for the active musculature was determined using the Borg 6-20 RPE scale (Borg, 1970). 
This is in accordance with protocols used to assess RPE following WANT testing and
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nutritional manipulation including caffeine ingestion (Woolf, Bidwell, & Carlson, 2008). Post
exercise blood lactate (Bla) was also determined 2 minutes after each test using a capillary 
blood sample from the earlobe (Lactate Plus, Nova Biomedical, USA).
Assessment of Blinding
After completion of all trials, participants were asked which trial they thought was the
caffeine and which the placebo trial. They were also asked to outline why they identified which 
trial as which. These responses were noted down by the researchers to address criticisms of
past studies on the effect of caffeine which have not assessed the efficacy of blinding (Grgic,
2018). The efficacy of blinding was then determined using Bang’s Blinding Index (Bang, Ni, &
Davis, 2004) to provide a standardised measure of participants guessing which substance
was ingested over chance.
Statistical analysis
In order to examine whether there were any differences in peak power, mean power,
fatigue index, Bla, PHR and RPE between caffeine and placebo conditions in upper and lower
body conditions a series of 2 (substance ingested) X 2 (mode; upper vs lower body) ways
repeated measures analysis of variance (ANOVA) were carried out. Where any significant
differences were found Bonferroni post-hoc pairwise comparisons were used to indicate where
the differences lay. Partial eta2 (Pη2) was also used as a measure of effect size. The Bang’s
Blinding Index was used for exploring the effectiveness of the blinding to the caffeine and
placebo conditions (Bang, Ni, & Davis, 2004). Given the limitations of data presentation using
bar graphs (Weissgerber, Milic, Winham, & Garovic, 2015), data were visually presented
following procedures advocated by Weissgerber et al. (2015) by presenting data distribution 
in figures to ensure more complete presentation of data. The statistical package for social
sciences (SPSS Version 25) was used for all analysis.
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Results
Mean ± SD and 95% CIs for peak power, mean power, fatigue index, Bla, PHR and 
RPE in caffeine and placebo conditions for each repetition of the upper and lower body WANT
are presented in Table 1. 
***Table 1 here***
Peak Power
For peak power there was no significant substance X mode interaction (P = .244). 
There were, however, significant main effects for substance ingested (P = .001, Pη2 = .541) 
and mode of exercise (P = .0001, Pη2 = .900). Bonferroni post-hoc pairwise comparisons 
indicated that WANT performance was significantly higher for upper and lower body combined
following caffeine ingestion compared to placebo (mean diff = 59.4, P = .001) irrespective of 
mode of exercise and that peak power was significantly higher during lower body WANTs
compared to upper body WANTs (mean diff = 322.9, P = .0001). Subsequent planned 
comparisons revealed no significant difference between caffeine and placebo conditions in 
the lower body (P = .193) or upper body (P = .104) WANTs. In both cases peak power was
higher in the presence of caffeine compared to placebo. A scatterplot showing the data 
distribution for peak power for each trial of the WANT in caffeine and placebo conditions is 
presented in Figure 1. 
***Figure 1 here***
Mean Power
For mean power there were no significant substance X mode interactions (P = .814,
Pη2= .003) nor was there a significant main effect for substance ingested (P = .114, Pη2= 
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.120). There was a significant main effect for mode of exercise (P = .0001, Pη2= .864) where
mean power was significantly lower in upper body compared to lower body WANT. A 
scatterplot showing the data distribution for mean power for each trial of the WANT in caffeine 
and placebo conditions is presented in Figure 2.
***Figure 2 here***
Fatigue Index
Data for fatigue index indicated no significant substance ingested X mode interaction (P = 
.08), nor was there a significant main effect for substance ingested (P = .941) or mode of
exercise (P =.639). 
Blood Lactate and Peak Heart Rate
For Bla there was no significant substance ingested X mode interaction (P = .091), nor
was there a significant main effect for substance ingested (P = .204) or mode of exercise (P 
=.183). The results for PHR followed a similar trend to those for Bla. There was no significant
substance ingested X mode interaction (P = .521), nor was there a significant main effect for 
substance ingested (P = .099) or mode of exercise (P =.109). 
Rating of Perceived Exertion
For RPE there was also a significant substance ingested X mode interaction (P = .001, 
Pη2 = .458). Post-hoc analysis indicated no significant difference in RPE between caffeine and
placebo in lower body WANT (P = .634, Pη2 = .012) but significantly lower RPE during upper 
body WANT in the presence of caffeine compared to placebo (P = .014, Pη2 = .253). Mean ± 
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SD and 95% CIs of RPE for each trial of the WANT in caffeine and placebo conditions is 
presented in Table1. 
Efficacy of Blinding
Post experiment responses in regard to participant awareness of which trial involved
caffeine and which placebo indicated 41% (n = 9) of participants correctly identified the upper
body caffeine or placebo trial, 45% (n = 10) incorrectly identified the correct trial. Reasons for
identification of trial as containing caffeine (irrespective of whether it was identified correctly 
or not) were because participants felt “more alert”, “more aware”, “ready to go”. Three
participants (14%) suggested they could not discern which upper body trial was which. In
regard to the lower body trials, 55% (n = 12) of participants correctly identified the caffeine or 
placebo trial and 36% (n = 8) incorrectly identified the correct trial. Similar reasons were
identified as with the upper body trials for which contained which alongside participants stating 
“I just know” which trial contained caffeine and “I could feel it”. In the case of the former this 
statement was made by participants who guessed correctly and incorrectly in terms of which 
substance contained caffeine and which placebo. Two participants (9%) stated they did not
know which lower body trial contained caffeine and which placebo. Results from the Bang
Blinding Index indicated that, for upper body trials, 5.8% and 5.2% of participants correctly 
guessed the caffeine and placebo trials beyond chance respectively. This figure was 5.8% 
and 9% for guessing caffeine and placebo trials beyond chance respectively in the lower body 
trials. 95% confidence intervals were -0.05 – 0.24 for upper body trials and -0.2 – 0.26 for
lower body trials. As the confidence intervals overlap the null this is indicative that blinding 
was highly effective and participants’ decisions as to which trial was which were more likely to 
be due to random guessing by the participants (Bang, Ni, & Davis, 2004).  
Additional a posteriori analysis was conducted using independent samples t-tests to
examine any differences in the caffeine trials and placebo trials for those who correctly
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guessed which substance they ingested versus those who incorrectly guessed. For lower body
and upper body WANTs there were no significant differences in peak power or mean power
(all P>0.05) for those who correctly identified the caffeine trial and those who did not. Mean ± 
SD for peak power during lower body WANT was 930 ± 215 Watts (4.1% improvement) versus 
893 ± 156 Watts and mean power was 580 ± 107 Watts (4.5% improvement) versus 555 ± 
120 Watts for those correctly identifying the caffeine trial compared to those who did not
respectively. For upper body trials mean ± SD was 604 ± 160 Watts (4.2% improvement)
versus 590 ± 122 Watts for peak power and 351 ± 130 Watts (3.2% improvement) versus 340
± 68 Watts for mean power for those who correctly identified the caffeine trial compared to 
those who did not. 
Discussion
This study examined the efficacy of acute caffeine ingestion on upper and lower body 
WANT anaerobic test performance. The results of the current study suggest that, when upper
and lower body exercise data are combined (i.e. a main effect), caffeine ingestion enhances
peak power production compared to placebo. This is the first study to compare the effects of
caffeine ingestion on upper and lower body 30 second WANT test performance and, as such,
this work makes an original contribution to the literature. Caffeine ingestion significantly 
enhanced peak power in both upper and lower body WANTs. Caffeine ingestion also
dampened RPE; however, this effect was noted only for upper body exercise. Mean power
and fatigue index were not significantly different as a consequence of substance ingested or
the mode of exercise. Blinding of the participants was generally effective and thus did not
confound the results. 
The ability to generate greater peak power during a 30-second exercise period is 
important in a number of cases. Notably, in BMX racing where peak power achieved within
the first five seconds of a race is indicative of overall race performance, lasting approximately 
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35 seconds (Rylands, Roberts, Hurst, & Bently, 2017). This is also the case for upper body 
peak power in grinders within America’s Cup sailing where peak power production is key to 
sailing performance (Neville, Pain, & Folland, 2009). The results of the current study align with
assertions made by Duncan et al. (2018) that reported increased peak power in the presence
of caffeine during upper body WANT performance. The results of the current study in respect 
to lower body WANT performance are also in agreement with some prior research examining
this topic (Duncan, 2009; Grgic, 2018, Salinero et al., 2017) but do not agree with studies 
(Greer et al., 1998; Pereira et al., 2010) that reported caffeine to have an ergolytic effect on 
lower body WANT performance. One study examined the effects of caffeine on upper and
lower body WANT performance using a repeated effort protocol (6 x 15 seconds). In the study
by Andre, Green, Gann, O’Neal, and Coates (2015) a caffeine dose of 7 mg*kg-1 ingested one
hour before the testing commenced, was effective for acute increases in peak and mean
power output in the upper but not lower body. However, in this study, the participants 
completed both the upper and lower body WANTs in the same sessions (with the upper body 
test always preceding the lower body WANT) while in our study, the performance in these
tests was examined on different testing days. It remains possible that caffeine was not
ergogenic for lower body in the study by Andre et al. (2015) due to the accumulated fatigue
from the upper body WANT given that in some cases, caffeine may become ergolytic as
fatigue develops (Bishop, 2010). Furthermore, the use of a repeated effort protocol (i.e., 6 x 
15 seconds) and the differences in caffeine doses (7 vs. 5 mg*kg-1) limit any further
comparison with the results observed herein. 
We did not observe significant effects of caffeine on mean power. However, the
percent differences between the placebo and caffeine conditions showed a ~5% favouring of
the caffeine conditions (both in the upper and lower body WANT). Therefore, it might be that
these results did not reach statistical significance due to the wide variation in responses to 
caffeine ingestion (Pickering & Kiely, 2018). Future studies are needed to explore the reasons 
for this variation in responses between individuals. While the improvement in performance
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following caffeine ingestion is small and could be questioned from a practical significance
standpoint, these results may be relevant for individuals interested in maximising their power
performance, for example, those participating in sports such as BMX. It is also important to
note that, following sub analysis of peak and mean power for participants who correctly 
guessed which substance was ingested, correctly guessing caffeine had been ingested in the
caffeine trials resulted in small (in the region 2.3-4.5%), but non-significant, improvements in
peak and mean power in both lower and upper body WANT. 
Previous studies examining upper and lower body exercise performance have
suggested that caffeine’s effects on exercise performance predominantly manifest in the large
muscles of the lower body (e.g., knee extensors) but not in smaller muscles of the upper body 
such as the arm flexors (Warren et al., 2010). However, such claims have been made in
relation to measures of upper body muscular strength and endurance using different 
resistance exercises that may not hold true for the upper body WANT. By virtue of the
requirements of the upper body WANT there is a likely greater contribution to the exercise of 
the abdominals, back, and chest as well as the arms which are not seen in upper body 
resistance exercise. The greater amount of muscle mass activated during WANT might
provide an explanation why caffeine is ergogenic for this type of a test—a finding in contrast
to some of the suggested different responses to caffeine between the upper and lower body 
(Warren et al., 2010). Aside from caffeine, somewhat surprisingly and given the range of 
ergogenic substances that have been studied in the context of improving human performance,
very few studies have compared the effects of ingestion of ergogenic aids on upper vs lower 
body anaerobic performance. Such information would be useful in demonstrating if such aids 
elicit region differences in performance of the upper and lower body. Only one other study
appears to have examined whether ingestion of an ergogenic aid, in this case, creatine
monohydrate, influenced upper vs lower body WANT performance (Green, McLester, Smith,
& Mansfield, 2001). In their study Green et al (2001) reported no differences in mean or peak 
power as a consequence of creatine ingestion on upper or lower body WANT performance. 
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The present study also suggests that caffeine ingestion dampens RPE compared to
placebo. Such a finding is apparent in the literature across aerobic and anaerobically based 
exercise modalities (Doherty, Smith, Hughes, & Davison 2004; Doherty & Smith, 2005;
Duncan, Stanley, Parkhouse, Cook, & Smith, 2013). However, RPE was only dampened for
upper body exercise and not lower body exercise. It remains unclear why we observed these
differences in responses. Therefore, additional research is needed to explore why caffeine
may have a RPE reducing effect during upper, but not lower body WANT.
There are some limitations to the current study. Prior work (e.g., Greer et al., 1998)
has employed a protocol involving four repeated WANTs. In the current study, we sought to
compare WANT performance with and without caffeine ingestion using upper and lower body
“all out” WANT versions, acting on suggestions for future research made in the recent meta-
analysis by Grgic (2018). Given the employed WANT version, any generalisation to repeat
effort protocols is limited and this area would be beneficial for future research to investigate.
We also acknowledge that blood sampling 2 minutes post exercise is more a reflection of post 
exercise values rather than peak blood lactate. The current study also included young males
as participants who were involved in regular exercise but not specifically athletes. Therefore, 
future work examining if caffeine has the same effect on the upper body and lower body WANT
performance in females and athletes competing in anaerobic-based sports would also be
useful. Future studies are also needed using different doses of caffeine in order to establish 
an “optimal” dose of caffeine for acute ergogenic effects. 
Conclusion
To conclude, ingestion of 5 mg*kg-1 body mass caffeine enhances peak power
production during the upper body and lower body WANT in non-specifically trained males
when data from upper and lower body trials are combined. Such results have application for 
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sports where there may be anaerobic power demands such as wheelchair sports, boxing,
rowing, and other sports that include all-out sprinting activities. 
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Figure 1. Scatterplot showing the data distribution (circles) and mean (horizontal bar) for 
peak power (watts) for the Wingate test in caffeine and placebo conditions.
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Figure 2. Scatterplot showing the data distribution (circles) and mean (horizontal bar) for 
mean power (watts) for the Wingate test in caffeine and placebo conditions.
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Caffeine Placebo
Upper Body Lower Body Upper Body Lower Body
M SD 95% CI M SD 95% CI M SD 95% CI M SD 95% CI
Peak Power (Watts) 574 148 500-640 880 192 796-965 498 262 423-573 850 198 761-938
Mean Power (Watts) 357 101 313-408 598 126 541-655 341 84 301-378 570 129 512-629
Fatigue Index (%) 72.8 14.1 57.4-84.5 73.4 12.4 64.4-82.3 70.8 13.7 59.4-86.3 69.8 12.1 61.2-78.4
Peak Heart Rate (bpm) 160 15 152-167 164 13 158-171 152 14 147-160 161 14 154-169
Blood Lactate (mmol/L) 9.9 3.9 8.1-11.8 11.9 2.8 10.5-13.2 11.5 3.2 10.6-13.1 11.4 2.11 10.4-12.4
RPE (6-20) 13.2 1.4 12.4-14.1 14.1 1.3 13.5-14.7 14.0 1.4 13.4-14.5 14.3 1.7 13.5-15.1
M: mean
SD: standard deviation
RPE: rating of perceived exertion
CI: confidence interval
